A phase Ib dose-escalation study of ZN-c3, a WEE1 inhibitor, in combination with chemotherapy in patients with platinum-resistant or -refractory ovarian, peritoneal, or fallopian tube cancer

S. Fu, A. Pasic, G. Richardson, Z. J. Vranjes, T. Meniawy, P. R. de Jong, F. Donate, A. A. Samatar, J. Rodriguez, P. Pultar, D. Voliotis

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)S618-S618
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - 2021
EventCongress of the European-Society-for-Medical-Oncology (ESMO) -
Duration: 16 Sept 202121 Sept 2021

Cite this